COVID Spike Protein Contains DNA Sequence Patented By Moderna THREE YEARS Before Pandemic Began, Scientists Discover
The SARS-CoV-2 spike protein contains a DNA sequence identical to a genetic code patented by pharmaceutical company Moderna three years before the COVID pandemic emerged, according to researchers.
A study published in Frontiers in Virology on Monday by an international team of researchers found that the SARS-CoV-2 furin cleavage site (FCS) contains a tiny bit of genetic code identical to a part of a gene patented by Moderna in 2016.
The researchers claim that since there is a 1 in 3 TRILLION chance Moderna’s patented sequence randomly appeared through natural evolution, that the China Virus may have mutated during experiments on human cells in a lab.
“The absence of CTCCTCGGCGGGCACGTAG from any eukaryotic or viral genome in the BLAST database makes recombination in an intermediate host an unlikely explanation for its presence in SARS-CoV-2,” the scientists wrote.
Moderna’s patented sequence is part of a gene called MSH3, which is comprised of about 3,300 units of genetic code known as nucleotides.
The code the researchers found contains 19 of those same nucleotides out of the 30,000-nucleotide composition that makes up SARS-CoV-2.
“The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” the researchers noted.
But some researchers are claiming the study doesn’t show anything meaningful.